The recent Supreme Court ruling clarified the standard for interpreting “active moiety exhibiting a pharmacological effect” when determining whether an approved active ingredient is a new substance eligible for a PTE.
The recent Supreme Court ruling clarified the standard for interpreting “active moiety exhibiting a pharmacological effect” when determining whether an approved active ingredient is a new substance eligible for a PTE.